Haleon PLC Total Voting Rights and Capital
02 September 2024 - 11:45PM
RNS Regulatory News
RNS Number : 5726C
Haleon PLC
02 September 2024
![Icon Description automatically generated](https://dw6uz0omxro53.cloudfront.net/3157797/ccc256dd-736f-4292-87f8-940debed2448.png)
Haleon plc: Total Voting
Rights and Capital
2
September 2024: As at 31 August 2024
the total number of shares issued by Haleon plc ("Haleon" or the
"Company") with rights to vote is 9,123,638,944 ordinary shares of £0.01
each. There are no ordinary shares held in Treasury.
The figure above may be used by shareholders (and others with notification
obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the Company under
the Disclosure and Transparency Rules of the
Financial Conduct Authority.
Notifiable interests in Haleon may
be sent to: company.secretary@haleon.com
The person responsible for arranging
the release of this announcement on behalf of Haleon is Amanda
Mellor, Company Secretary.
About Haleon
Haleon (LSE / NYSE: HLN) is a global
leader in consumer health, with a purpose to deliver better
everyday health with humanity. Haleon's product portfolio spans
five major categories - Oral Health, Pain Relief, Respiratory
Health, Digestive Health and Other, and Vitamins, Minerals and
Supplements (VMS). Its long-standing brands - such as Advil,
Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident,
parodontax and Centrum - are built on trusted science, innovation
and deep human understanding.
For more information, please
visit www.haleon.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVRUUOORSBUKRAR
Haleon (LSE:HLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Haleon (LSE:HLN)
Historical Stock Chart
From Sep 2023 to Sep 2024